Q4 2023 scPharmaceuticals Inc Earnings Call Transcript
Yes, greetings, and welcome to SC. Pharmaceuticals Fourth Quarter and Full Year 2023 earnings conference call that at this time, all participants are in a listen-only mode and a question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce [T.J. Gallagher] with LifeSci Advisors. Thank you. You may begin.
Thank you, operator. And before turning the call over to management, I would like to make the following remarks concerning forward-looking statements. All statements on this conference call other than historical facts are forward-looking statements within the meaning of the federal securities laws, including but not limited to, statements regarding SC pharmaceuticals, expected future financial results and mint and mint expectations and plans for the business and for OpEx. The words anticipate, believe, estimate, expect
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |